Clearside Biomedical Presents Compelling Data at The Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting : vimarsana.com

ALPHARETTA, Ga., April 27, 2023 -- Clearside Biomedical, Inc. , a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space ,... | April 27, 2023

Related Keywords

Massachusetts , United States , Canada , China , India , South Korea , New Zealand , Australia , Triamcinolone Acetonide Suprachoroidal , Remy Bernarda , Dennism Marcus , George Lasezkay , Peter Yuwei Chang , Jenny Kobin , Surgery Institution , Exchange Commission , Nasdaq , Md Southeast Retina Center , Preclinical Development , Association For Research , Clearside Biomedical Inc , Va Physician , Massachusetts Eye Research , Globenewswire Inc , Company Publications , Drug Administration , Chief Executive , Extension Study , Tolerability Study , Suprachoroidal Injection , Persistent Activity Following , Vice President , Early Adoption , Triamcinolone Acetonide Suprachoroidal Injection , Uveitic Macular Edema , Physician Survey , Yuwei Chang , Eye Research , Tolerability Results , All Cohorts , Month Extension Study , Optical Coherence Tomography , Suprachoroidal Space , Injection Platform , Neovascular Age Related Macular Degeneration , Arctic Vision , Safety Information , Private Securities Litigation Reform Act , Annual Report , Periodic Reports , Media Contacts , Clearside Biomedical , Nc Stock Exchange , News , Nformation , Ress Release , Pril , 023 , Learside , Iopharmaceutical , Ompany , Revolutionizing , He , Elivery , F , Herapies , O , Ack , Ye , Hrough , Uprachoroidal , Pace Clsd Us1850631045 ,